JSM 2012 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program HomeActivity Details
|
|||
343 * | Tue, 7/31/2012, 10:30 AM - 12:20 PM | CC-Room 27B | |
Selected Analysis and Bioequivalence — Contributed Papers | |||
Biopharmaceutical Section | |||
Chair(s): Jin Xu, Merck | |||
10:35 AM | Optimizing Bioequivalence Trial Sample Size — Bret Musser, Merck ; Junghoon Lee, Merck ; Larson Patrick, Merck | ||
10:50 AM | Designs for Bayesian Adaptive Bioequivalence Trials — Cheng Zheng, Novartis ; Jixian Wang, Novartis | ||
11:05 AM | Group Sequential Method for PK Bioequivalence Crossover Studies — Huaixiang Li, FDA/OTS/CDER/OB/DBG ; Stella Grosser, FDA/CDER | ||
11:20 AM | On the Asymmetrical Margins Approach to Biosimilarity Clinical Trials with Efficacy Endpoints — Yulan Li, Novartis ; Qing Liu, Johnson & Johnson | ||
11:35 AM | Operating Characteristics in Assessing Agreement Between Two Instruments of Quantitative Measurement — Jeng Mah, Beckman Coulter | ||
11:50 AM | A Statistical Approach to Determining the Minimum Bead Number for Luminex Bead--Based Assays — Yuan (Sally) Zhang, Boehringer Ingelheim Pharmaceuticals, Inc. ; Xiaoyu Jiang, Novartis Institutes for BioMedical Research ; Shuguang Huang, Precision Therapeutics, Inc. | ||
12:05 PM | Floor Discussion |
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.